WHAT:

Barbara Sahakian, a world-renowned cognitive researcher and Penn Distinguished International Scholar, will present "Cognitive Enhancing Drugs: Neuroscience and Society," the first public talk in the Neuroscience & Society Lecture Series at the University of Pennsylvania.

WHO:

Sahakian, a professor at the University of Cambridge, is a leading expert on the effects of cognitive enhancing drugs on normal, healthy individuals, young and old. Her research is aimed at understanding the neural basis of cognitive, emotional and behavioral dysfunction in order to develop more effective pharmacological and psychological treatments. Recently, results from studies of ecstasy use and cognitive enhancement using methylphenidate, modafinil and atomoxetine have led to her interest in pharmacogenomics and neuroethics.

RSVPs can be sent to info@neuroethics.upenn.edu.

WHERE:

College Hall, Room 200, between 34th and 36th streets on Locust Walk, campus of the University of Pennsylvania

WHEN:

Thursday, Oct. 8, 2009, 4-5:30 p.m.

###

« previous | next »

News at a Glance for
» Natural Science
» Health & Medicine

Police Accreditation Team Invites Public Comment about Penn Police

Penn Hosts Daylong Arts Crawl Today

University of Pennsylvania Receives Top Ranking in Public Safety for Educational Facilities

Inaugural Group of Penn Eco-Reps Seeks to Educate, Change Residents’ Eco-Behavior at Three College Houses

Penn and Milken Family Foundation Launch Global Business Plan Competition to Improve Education

For general inquiries, call 215-898-8721.

For specific inquiries, please refer to our detailed listing of news officers.

Office of University Communications, 200 Sansom Place East, 3600 Chestnut Street, Philadelphia, PA 19104-6106.